- Home>
- Watch Topics>
- Hepatitis
Hepatitis
The latest information on cirrhosis, interferon, ribavirin, vaccines, and more, drawn from across our primary care and specialty care areas. Sign up now for monthly e-mail alerts on new content.
Entecavir Inhibits HIV at Reduced Viral Inoculum
- Infectious Diseases
- Summary and Comment
- Subscription required
The HBV drug entecavir has anti-HIV activity at a low viral inoculum and shouldnt be used in HIV/HBV-coinfected patients who are not receiving combination ART.
- By Lynn L. Estes, PharmD
- May 14, 2008
- Covering Antimicrob Agents Chemother 2008 May
Individualization of Treatment Duration in Genotype 1 HCV-Positive Patients
- Gastroenterology
- Summary and Comment
- Subscription required
Is it time to stop treating all HCV-positive patients the same way?
- By Atif Zaman, MD, MPH
- April 4, 2008
- Covering Hepatology 2008 Jan
Pentoxifylline for Severe Alcoholic Hepatitis
- Gastroenterology
- Summary and Comment
- Subscription required
Patients with severe alcoholic hepatitis who do not respond to corticosteroids gain no benefit from switching to pentoxifylline.
- By Atif Zaman, MD, MPH
- March 28, 2008
- Covering J Hepatol 2008 Mar
Telbivudine vs. Adefovir for Chronic HBV
- Gastroenterology
- Summary and Comment
- Subscription required
Telbivudine showed greater antiviral effects than did adefovir after 24 weeks of treatment in patients with chronic HBV infections.
- By Atif Zaman, MD, MPH
- March 21, 2008
- Covering Ann Intern Med 2007 Dec 4
HCV/HIV: Good News, Continued Challenges
- HIV/AIDS
- Meeting Report
- Subscription required
Data from the 15th Retrovirus Conference addressed numerous questions around HCV treatment in HIV-coinfected patients.
- By Rajesh T. Gandhi, MD
- March 10, 2008
Extended Interferon Therapy in HCV-Positive Slow Responders
- Gastroenterology
- Summary and Comment
- Subscription required
Sustained virologic response was significantly higher among slow responders who were treated with 72 weeks of pegylated interferon plus ribavirin.
- By Atif Zaman, MD, MPH
- March 7, 2008
- Covering Hepatology 2007 Dec
Outcomes of HCV Screening in a High-Risk Population
- Gastroenterology
- Summary and Comment
- Subscription required
Nearly one half of all veterans who were found to have chronic HCV infections in a targeted screening program were considered to be candidates for treatment.
- By Atif Zaman, MD, MPH
- February 29, 2008
- Covering Am J Gastroenterol 2008 Jan
Chronic HBV Infection with Persistently Normal ALT Levels
- Gastroenterology
- Summary and Comment
- Subscription required
Researchers find marked histologic damage in HBV-infected patients with persistently normal alanine aminotransferase levels.
- By Atif Zaman, MD, MPH
- February 22, 2008
- Covering J Hepatol 2007 Dec
Chronic Hepatitis E?
- Infectious Diseases
- Summary and Comment
- Subscription required
Investigators in France provide convincing evidence of chronic HEV infection in organ-transplant recipients.
- By Larry M. Baddour, MD
- February 20, 2008
- Covering N Engl J Med 2008 Feb 21
Prolonged Entecavir vs. Lamivudine for HBV
- Gastroenterology
- Summary and Comment
- Subscription required
Entecavirs efficacy and resistance profile remained superior to that of lamivudine at 96 weeks.
- By Atif Zaman, MD, MPH
- February 8, 2008
- Covering Gastroenterology 2007 Nov
